Month: September 2023

Massachusetts named healthiest state for third consecutive year ATLANTA and BOSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) — Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, in partnership with the Boston University School of Public Health (BUSPH), today released the annual Sharecare Community Well-Being Index 2022 state rankings report, with Massachusetts claiming the title of the healthiest state in America for the third consecutive year. Built on more than a decade of measurement and over 5 million surveys completed to date, the nationally representative dataset comprising the Sharecare Community Well-Being Index is the most comprehensive assessment of community health in the country. As in previous years, Sharecare’s proprietary research assessed the well-being of nearly...

TORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) — QuantGate Systems Inc (OTCQB: QGSI), the pioneering Artificial Intelligence (AI) and Machine Learning (ML) fintech solution company, is pleased to introduce a groundbreaking feature in the Pilot Trading Platform and App – AI Signals Only Mode. This revolutionary addition offers real-time data from over 60,000 assets by processing a staggering 5 billion calculations per second. It further enhances the innovative app designed to revolutionize traders’ experiences. The feature will be accessible on desktop and mobile devices, including iOS and Android, starting September 12, 2023. Powered by cutting-edge Artificial Intelligence (AI) technology, the Pilot Trading app offers traders a timely window (0 to 10 minutes) into the probable developing structure of a security in multiple...

New Capabilities to Interpret Content Will Improve Speed and Accuracy of Evaluating Medical Records FORT WORTH, Texas, Sept. 12, 2023 (GLOBE NEWSWIRE) — CorVel Corporation (NASDAQ: CRVL) today announced the release of its initial Generative AI module. A new addition to CorVel’s CogencyIQ® service offerings, the module will leverage machine learning to interpret medical records for adjusters and prompt immediate actions. Interpreting medical data and determining the next steps in managing a case is critical and time-consuming for adjusters. CorVel’s generative AI model will now read and summarize this often-complex information, provide the summary to the adjusters, and propose actions to be taken. Simultaneously, the extraction of unstructured data from the reports will be highlighted for the claims staff to quickly and efficiently...

Banco Comercial Português, S.A. informs about the upgrade to Investment Grade of senior debt ratings by S&P GlobalAttachment2023 09 12 Upgrade SP EN

VANCOUVER, Sept. 12, 2023 (GLOBE NEWSWIRE) — Spirit Blockchain Capital Inc. (CSE: SPIR), a leading multi-strategy investment manager in blockchain infrastructure and digital assets, proudly celebrates its one-year anniversary since its debut initial public offering on the Canadian Securities Exchange. Despite the challenging market conditions in 2022 and 2023, Spirit Blockchain Capital emerges as a stronger, more resilient player in the industry. Spirit Blockchain Capital is also thrilled to introduce key executive appointments that will play a pivotal role in our continued success. Francisco Lung, CFA, MBA, a distinguished financial expert with over 20 years of diverse experience in traditional capital markets and digital asset management, joins us as Chief Investment Officer (CIO), bringing a wealth of experience in investment...

ATLANTA, Sept. 12, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat debilitating chronic diseases such as fibromyalgia (“FM”) and Long-COVID (“LC”), announced today that Greg Duncan, Chairman and Chief Executive Officer, will present at the SHARE™️ Series Monday Management Update for investors on Monday, September 18, 2023, at 11:00 am ET. This virtual event combines a brief corporate overview with a moderated fireside chat and provides access to individual and institutional investors who will have the opportunity to submit questions during the live session. A link to the live and archived webcast may be accessed on the Virios Therapeutics website under the Investors section: Events and...

Live Product Demonstrations Yield Numerous Customer EngagementsDr. Mo Jinyu at IFOC conferencePresentation at IFOC ConferencePOET CIOE Booth AttendeesAttendees at POET CIOE BoothTORONTO, Sept. 12, 2023 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center, telecommunication and artificial intelligence markets, today announced that its joint exhibition with Super Photonics Xiamen (SPX) at the China International Optoelectronics Expo (CIOE) in Shenzhen earlier this month was an outstanding success that signals more near-term commercial activity for the Company. The objective for both POET and SPX was to feature 800G optical transceiver solutions...

The 250,000-metric-ton Direct Air Capture credit removal purchase is the technology industry’s largest agreement with 1PointFive HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) — 1PointFive, a carbon capture, utilization and sequestration company, today announced that Amazon (NASDAQ: AMZN) has agreed to purchase 250,000 metric tons of carbon dioxide removal (CDR) credits over 10 years. The agreement furthers Direct Air Capture (DAC) as a viable carbon removal solution to help organizations further their climate goals. The CDR credits for Amazon will be enabled by STRATOS, 1PointFive’s first commercial-scale DAC plant, currently under construction in Texas. The plant is designed to capture up to 500,000 metric tons of CO2 annually when fully operational, making it the largest plant in the world, and a milestone in reaching climate relevant...

BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Estradiol Tablets USP. ANI’s Estradiol Tablets USP are the generic version of the Reference Listed Drug (RLD) Estrace®. The According to IQVIA, a leading healthcare data and analytics provider, the current annual U.S. market for Estradiol Tablets USP is approximately $40.9 million. “The approval and launch of Estradiol Tablets, so quickly following our launch last month of Estradiol Gel, exemplifies the ongoing strength of ANI’s Generics portfolio as well as our ongoing commitment in ensuring that patients and providers have access to the high-quality medications they depend on,” stated...